Rammohan Devulapally

Company: LifeEdit Therapeutics

Job title: Director, Nonviral Delivery

Bio:

Ram heads non-viral delivery at Life Edit Therapeutics. Previously, Ram led non-viral gene delivery at GenEdit, lipid nanoparticle platform development at ReCode Therapeutics, and held research positions at Stanford University and Texas A&M University.

Seminars:

Panel Discussion: Current Impact & Future Directions of Emerging Non-Viral CRISPR Delivery Methods 10:00 am

Outlining novel formulations being developed to target non-hepatic tissues in vivo What progress has been made in the past year to progress the safety and efficacy of these delivery methods Where are the remaining research gaps for effective tissue-targeting delivery systems?Read more

day: Day 2 AM

Enabling Tissue-Specific in vivo Targeting With Lipid Nanoparticles 12:00 pm

Outlining the key challenges facing tissue-specific CRISPR delivery Examining the impacts of LNP composition on tissue targeting Understanding the role of surface ligand conjugations for non-hepatic targeting and hepatic detargetingRead more

day: Pre-Conference Delivery Focus Day